Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

R&D

Identification of a predictive model for therapeutic guidance in diffuse large B-cell lymphoma by means of systems pathology

To confirm the association between MYC translocation and patient’s survival. To combine the results obtained by BCL6 and MYC mplex immunofluorescence and FISH in multivariate analysis in order to identify a robust phenotype associated with DLBCL patient’s outcome and overall survival. Multiplexed Immunofluorescence study of new markers involved in tumor progression and treatment resistance

Drs. Elías Campo y Lluís Colomo, Fundació Clínic per a la Recerca Biomèdica, Hospital Clínic.

ACC1Ó-FEDER; La Caixa

Valera et al, Haematologica, 2013

P7304PC00-PCT/EP2012/067815